Merck Secures All Antitrust Approvals for Sigma-Aldrich Acquisition
Completion of transaction expected in third quarter 2015
Merck announced that approvals have been secured from all relevant jurisdictions for its planned acquisition of U.S.-based life science company Sigma-Aldrich.
Unconditional approval from Brazil’s Council for Economic Defense (CADE), which was the final outstanding country, was received.
Merck expects a completion of the transaction in the third quarter 2015. The closing of the transaction is still subject to the Commitments made to the European Commission, following its conditional approval of the transaction, announced on June 15, 2015. As a result, Merck and Sigma-Aldrich have agreed to sell parts of Sigma-Aldrich’s solvents and inorganics business in Europe.
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents

Tierra Biosciences Launches First-Ever Online Protein Ordering Platform for Synthetic Biology Protein Engineering - Sourcing thousands of proteins for research and development

Lethal combination: Drug cocktail turns off the juice to cancer cells
Rice wins NIH funding for oral-cancer test - Grand Opportunity grant funds rapid saliva test using lab-on-a-chip
Agilent Technologies Presents Thought Leader Award to Lipidomics Expert Dr. Jules Griffin - Cambridge Researcher to Further Studies of Obesity, Fatty Liver Disease
Plant Biotechnology Has Gone Global With Research and Production Underway in 63 Countries - Biotech Crops Generate $27.5 Billion in Value in United States

Laboratorios VM Ltda. - Bogotá, Colombia
Fast-Growing Market for SNPs Products Continues to Grow
Genmab Acquires Antibody Assets from iDD Biotech
Strand Genomics changes corporate identity to Strand Life Sciences
TET Systems and Novo Nordisk sign license agreement
